187 related articles for article (PubMed ID: 35471813)
21. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding.
Tie J; Gou X; He C; Li K; Yuan X; Jia W; Niu J; Han N; Xu J; Zhu Y; Wang W
Hepatol Int; 2023 Aug; 17(4):979-988. PubMed ID: 37097537
[TBL] [Abstract][Full Text] [Related]
22. [Transjugular intrahepatic portosystemic shunt (TIPS)].
Peck-Radosavljevic M; Pidlich J
Wien Klin Wochenschr; 2000 Nov; 112(22):947-54. PubMed ID: 11142132
[TBL] [Abstract][Full Text] [Related]
23. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
[TBL] [Abstract][Full Text] [Related]
24. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
[TBL] [Abstract][Full Text] [Related]
27. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
[TBL] [Abstract][Full Text] [Related]
28. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
Hung ML; Lee EW
Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
[TBL] [Abstract][Full Text] [Related]
29. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
30. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
[TBL] [Abstract][Full Text] [Related]
31. [30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives].
Schultheiß M; Bettinger D; Thimme R; Rössle M
Z Gastroenterol; 2020 Sep; 58(9):877-889. PubMed ID: 32947633
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
33. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
Brown RS; Lake JR
Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
[TBL] [Abstract][Full Text] [Related]
34. Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.
Gao L; Li MB; Li JY; Liu Y; Ren C; Feng DP
World J Gastroenterol; 2023 Oct; 29(38):5383-5394. PubMed ID: 37900585
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
36. A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt.
Appenrodt B; Schepke M; Kuntz-Hehner S; Schmiedel A; Sauerbruch T
Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):447-9. PubMed ID: 16538120
[TBL] [Abstract][Full Text] [Related]
37. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
Lyu Y; Han GH; Fan DM
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):402-407. PubMed ID: 28763854
[TBL] [Abstract][Full Text] [Related]
38. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
[TBL] [Abstract][Full Text] [Related]
39. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
Bucsics T; Schoder M; Goeschl N; Schwabl P; Mandorfer M; Diermayr M; Feldner M; Riedl F; Bauer D; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T
Dig Liver Dis; 2017 Dec; 49(12):1360-1367. PubMed ID: 28869158
[TBL] [Abstract][Full Text] [Related]
40. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
